@wcmenglanderipm.bsky.social
Don't miss next Friday's Englander Institute for Precision Medicine's Liquid Biopsy Platform talk on "How the Bone Microenvironment Reprograms CTCs for Metastatic Expansion," by Dr. Igor Bado (@BadoIgor) from @IcahnMountSinai! #metastasis
“These findings suggest that combining 177Lu-PSMA-617 with standard of care hormonal therapy offers patients more time without [Prostate Cancer] disease progression," said Dr. Scott Tagawa from the EIPM. www.diagnosticimaging.com/view/fda-exp...
FDA Expands Approval of Pluvicto in Combination with ARPI for PSMA-Positive mAPMN/S Prostate Cancer | Diagnostic Imaging
Based on results from the phase III PSMAddition trial, the expanded approval may nearly double the number of patients with prostate cancer who can be treated with Pluvicto.
diagnosticimaging.com
We thank Drs. Eda Nur Kozan and Jesus Delgado De La Mora (@Jesusdelmora) from @WCMCPathology for leading yesterday's @WCMEnglanderIPM #PrecisionMedicine Journal Club and providing their insight on recent @NatureMedicine #LungCancer articles!
We conclude #SpritWeek @WCMEnglanderIPM with #FancyDay as our young staff sport cocktail attire in the wet lab. We hope you enjoyed following us this week as much as we enjoyed showing off our excitement for science! Also, there will be happy hour cocktails after work...
We hope to see you today at 3 pm for our next EIPM #PrecisionMedicine Journal Club featuring Drs. Eda Nur Kozan and Jesus Delgado De La Mora (@Jesusdelmora) from the WCM Dept. of Pathology and Laboratory Medicine for their insight on recent @NatureMedicine #LungCancer articles!
Inspired by the recent #WorldCup & @nyknicks NBA championship, it's a #LabOlympics theme for day four of #SpritWeek @WCMEnglanderIPM! Fun games and sporty clothes will help our young staff stay focused in the lab today as they advance science and speed treatments to patients.
“This study provides an important reminder that the causes are multifactorial and differ by tumor type,” Dr. Lisa Newman, an EIPM Member, told Medscape Medical News. www.medscape.com/viewarticle/...
Which Cancers Are Still More Deadly in Black Patients?
A comprehensive analysis of the cancer mortality gap between Black and White people shows progress overall, but disparities in a few types are unchanged or worse.
medscape.com
Throw those hearts for day three of #SpritWeek, it's #MatchingDay at the EIPM! Our young (and not so young) staff will be decked-out in the wet lab today in matching blue jeans, white t-shirts, and white sneakers while they advance science and speed treatments to patients. Also, a dance contest?
Don't miss tomorrow's EIPM Precision Medicine Journal Club, featuring Drs. Eda Nur Kozan and Jesus Delgado De La Mora (@Jesusdelmora) from WCM's Department of Pathology and Laboratory Medicine discussing recent Nature Medicine lung cancer articles!
Day two of #SpritWeek brings #EmoDay @WCMEnglanderIPM's wet lab in the Belfer Research Building! Our young colleagues may look like sullen teens today, but these brilliant professionals are hard at work doing amazing things to advance science & speed new treatments to patients!
"Comparison of whole genome sequencing with clinical targeted panel sequencing of metastatic prostate cancer," was just published in Precision Oncology by Dr. Juan Miguel Mosquera from the Department of Pathology and Laboratory Medicine and EIPM, with colleagues. www.nature.com/articles/s41...
Today we kick off #SpritWeek with #PajamaDay at the EIPM's wet lab in the Belfer Research Building at Weill Cornell Medicine! They may look sleepy, but our young colleagues are fully caffeinated and hard at work advancing science and speeding new treatments to patients!
Great EIPM Precision Medicine conference yesterday featuring WCM Pathology and Laboratory Medicine's Dr. Neal Lindeman discussing "CAP/IASLC/AMP Guidelines for the Molecular Testing of Lung Cancers for Treatment with Targeted Therapies," thanks to all who participated!
Don't miss our next EIPM Precision Medicine Journal Club next Thursday featuring Drs. Eda Nur Kozan and Jesus Delgado De La Mora (@Jesusdelmora) from WCM's Pathology and Laboratory Medicine department discussing recent Nature Medicine lung cancer articles!
Another great Genetic Engineering & Biotechnology News article "Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow," recaps a recent Leukemia journal paper by EIPM Drs. Pinkal Desai, MonicaGuzman, Giorgio Inghirami & Shahin Rafii! www.genengnews.com/topics/cance...
Blood Cancer Therapies Informed by Spatial Remodeling of Bone Marrow
An AI-based approach assesses disease severity in patients with myelodysplastic neoplasms (MDS), a form of blood cancer.
genengnews.com
Great new Drug Target Review article "Tumour organoids may expand access to targeted cancer drugs," highlighting the work of EIPM researchers who developed a library of 220 patient-derived tumour organoids spanning 15 cancer types! www.drugtargetreview.com/tumour-organ...
Tumour organoids may expand access to targeted cancer drugs
Two studies from Weill Cornell Medicine demonstrate that patient-derived tumour organoids can accurately replicate cancers long-term and incorporate immune microenvironments, offering new potential fo...
drugtargetreview.com
Great new article in Genetic Engineering and Biotechnology News, "Patient-Derived Tumor Organoids Show Promise for Personalizing Cancer Treatment," featuring new research in ScienceAdvances by Drs. Sboner and Mosquera! www.genengnews.com/topics/cance...
Patient-Derived Tumor Organoids Show Promise for Personalizing Cancer Treatment
Researchers developed a 220-sample pan-cancer patient-derived organoid platform that faithfully mirrors tumors and may identify new treatment opportunities.
genengnews.com
Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer. "We are poised to harness technology to answer real-world clinical questions," said Dr. Pinkal Desai, Clinical Director of the EIPM's Molecular Aging Institute! eipm.weill.cornell.edu/news/mapping...
We hope you enjoy "Tumor Organoid Tech Advances Toward a Sci-Fi Future," highlighting two new studies by EIPM researchers on progress in precision medicine and use of tumor organoids as models for evaluating and optimizing cancer treatments: eipm.weill.cornell.edu/news/tumor-o...
New Communications Biology paper, "Temporal and spatial control of phosphatidylinositides using optogenetics ameliorates behavioral deficits in an Alzheimer's disease mouse model" by our EIPM colleague Dr. Jan Krumsiek! www.nature.com/articles/s42...
We hope you can join us a week from today, in-person or via Zoom!
Check out the new Nature Communications paper, "A quantitative approach for defining the degradability landscape of protein degraders," by EIPM Drs. Olivier Elemento, Ben Hopkins, Lamberto De Boni, and first author Wei Du--Director Elemento's former PhD student! www.nature.com/articles/s41...
Don't miss Friday's EIPM Precision Medicine AI Working Group talk "Probing and Rescuing Dysfunctional Brain Circuits in Depression," by Dr. Conor Liston from Weill Cornell Medicine's Brain and Mind Institute and the Department of Psychiatry!
An analysis led by Weill Cornell Medicine and Duke University, researchers found that in some cases cancer progression was detected on scans even when PSA levels were undetectable. Learn more in this @oncodailynews post by EIPM Clinical Director Dr. Cora N. Sternberg: oncodaily.com/voices/weill...
Imaging Scans Detect Prostate Cancer Progression Despite Stable PSA Levels - Weill Cornell Medicine - OncoDaily
Imaging Scans Detect Prostate Cancer Progression Despite Stable PSA Levels - Weill Cornell Medicine / Andrew Armstrong, cancer, Cora Sternberg, Duke
oncodaily.com
Biological age often diverges from chronological age, yet its independent impact on surgical outcomes remains poorly defined. A new paper by our colleagues evaluates PhenoAge, a validated biological age metric, in an international multi-cohort study. Learn more: www.nature.com/articles/s41...
Congrats to EIPM member Dr. Eleni Andreopoulou on being the first woman to earn an Honorary Professor of Medicine from the University of Ioannina Medical School in Greece in recognition of her contributions to teaching & mentorship!
“We found that up to roughly 25% of patients had radiographic prostate cancer progression without any rise in PSA levels, and they had worse outcomes,” said EIPM's Clinical Director Dr. Cora N. Sternberg. eipm.weill.cornell.edu/news/psa-lev...
Our EIPM Director Olivier Elemento (@ElementoLab) has a terrific News & Views article in today's #Nature, "AI systems devise hypotheses and ways to test them." www.nature.com/articles/d41...
AI systems devise hypotheses and ways to test them
AI agents collaborate to generate biomedical hypotheses and analyse data, moving towards a laboratory discovery cycle with AI involved in every step.
nature.com
